ArticleNeurology and therapy2026

Maintenance of Minimal Manifestation Status with Individualized-Interval Efgartigimod in Generalized Myasthenia Gravis: Study Protocol for a Single-Arm, Open-Label Clinical Trial.

Tetsu Suzuki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.